| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |